NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/07/2022
Voltar para busca
Dado oficial do USPTO
PRECISION ADVANCE THE CELL & GENE THERAPY COLLECTIVE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
18
Atualização mais recente
26/07/2022
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
35, 41, 42
Data de depósito
03/03/2021
Data de registro
26/07/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/07/2022
Última transação
26/07/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
14/01/2021
Primeiro uso no comércio
14/01/2021
Código do desenho
3
Tipo de titular
16
Localização do titular
Bethesda, MD, US
Examinador
DUBIN, DAVID I
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized gray word "PRECISION" stacked above the stylized green word "ADVANCE" that is followed by a green forward slash design, which is followed by the stylized black wording "THE CELL & GENE THERAPY COLLECTIVE". The stylized wording and design, as illustrated in the mark, are featured on top of a white rectangular background, which is not a claimed feature of the mark.
Titulares e representantes
Titulares
Precision Medicine Group, LLC
Representantes
Donna H. Hartman OLENDERFELDMAN LLP
Classificação técnica
Classes Nice
Classe 35Classe 41Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business management consulting services provided to pharmaceutical and life sciences companies to provide advice and business strategies to conduct and manage research and clinical development of targeted therapies and diagnosticsclinical solutionsregulatory guidancehealth economics designlaunch planningaccess strategypromotional effectivenessmarket adoption; business management consultation in the field of promotion opportunity assessmentpromotion effectivenesspayer promotion strategyaccount manager and sales force promotion strategy and distribution strategy; business management and business management consulting services in the fields of healthcarepharmaceuticalsbiotechnologymedical devicesfood and nutrition; public policy consulting services in the fields of healthcarepharmaceuticalsbiotechnologymedical devicesfood and nutrition; business consulting services provided to the healthcare industry in the nature of the creationcollectionanalysisreporting of data and information for support of business and public policy decision-making; provision of statistical and commercial and business information in the fields of healthcarepharmaceuticalsbiotechnologymedical deviceshealth insurancefood and nutrition
Classe 41
Providing non-downloadable electronic publications in the nature of informational reports for support of business and policy decisions for the healthcare industry
Classe 42
Scientific consulting services in the fields of healthcarepharmaceuticalsbiotechnologymedical devicesfood and nutrition; scientific consulting services for the health insurance industry; provision of scientific research information in the fields of healthcarepharmaceuticalsbiotechnologymedical deviceshealth insurancefood and nutrition; providing medical and scientific research information in the field of clinical trials as they relate to healthcarepharmaceuticalsbiotechnologymedical devicesfood and nutrition
Publicações
Histórico de despachos e eventos da marca no USPTO.
18 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
26/07/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/05/2022
PUBO
PUBLISHED FOR OPPOSITION
10/05/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/04/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/04/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/04/2022
CEPE
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
29/07/2021
ALIE
ASSIGNED TO LIE
29/07/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/07/2021
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
22/07/2021
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
22/07/2021
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
22/07/2021
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
22/07/2021
DOCK
ASSIGNED TO EXAMINER
21/07/2021
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/06/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/06/2021
NWAP
NEW APPLICATION ENTERED
06/03/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PRECISION ADVANCE THE CELL & GENE THERAPY COLLECTIVE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.